We repeated a similar experiment by co-culturing HT29 cancer cells with hepatocytes in the presence of LSKL (Leucine-Serine-Lysine-Leucine), an inhibitor of TSP1-mediated TGFβ1 activation66,67. The gene discussed is THBS1; the disease is cancer.